|
|
|
Westin Boston Waterfront, 425 Summer Street, Boston, MA 02210, USA
October 8-10, 2014
October 8-9 - Targeting Epigenetic Readers and Chromatin Remodelers
- Targeting the Ubiquitin Proteasome System
- Big Data Analytics and Solutions
- GPCR-Based Drug Discovery
- RNAi for Functional Genomics Screening – Part 1
- Protein-Protein Interactions as Drug Targets
- Antibodies Against Membrane Protein Targets – Part 1
October 9-10 - Targeting Histone Methyltransferases and Demethylases
- Screening Drug Transporter Proteins
- Maximizing Efficiency in Discovery
- GPCR-Targeted Therapeutics
- Genome Editing for Functional Genomics Screens – Part 2
- Cancer Metabolism
- Antibodies Against Membrane Protein Targets – Part 2
|
|
|
|
|
|
Organized by:
|
|
Cambridge Healthtech Institute (CHI) |
|
Invited Speakers:
|
|
- Masanori Aikawa, Ph.D., Yoshihiro Miwa Assoc Chair & Dir, Ctr for Interdisciplinary Cardiovascular Sciences, Brigham & Womens Hospital
- Bernard Allan, Ph.D., Sr Scientist, Molecular Biology, Genentech Inc
- Andrew Alt, Ph.D., Sr Research Investigator II, Lead Discovery, Bristol Myers Squibb Co
- Stephen Antonysamy, Ph.D., Principal Research Scientist, Structural Biology, Eli Lilly & Co
- Cheryl Arrowsmith, Ph.D., Principal Investigator, Medical Biophysics, Univ of Toronto
- Irfan Asangani, Ph.D., Research Investigator Pathology, Michigan Ctr for Translational Pathology, Univ of Michigan
- Geoffrey Bartholomeusz, Asst Prof, Experimental Therapeutics, MD Anderson Cancer Ctr
- Louise Baskin, Sr Product Manager, Dharmacon Products, Thermo Fisher Scientific Inc
- Eralp Al Bellibas, M.D., Sr Dir & Head, Clinical Pharmacology, Medicines Co
- Alexander Bishop, Asst Prof Cellular & Structural Biology, Greehey Childrens Cancer Research Institute, Univ of Texas San Antonio
- James Bradner, Asst Prof, Hematologic Oncology, Dana Farber Cancer Institute
- David Bramhill, Founder, Bramhill Biological Consulting LLC, Individual Consultant
- Abraham Brass, Asst Prof, Microbiology & Physiological Systems, Univ Of Massachusetts
- David Budd, Ph.D., Honorary Lecturer Inflammation, Ctr for Rheumatology & Connective Tissue Diseases, Univ College London
- Eugen Buehler, Team Leader, Informatics, NIH NHGRI
- Mark Bures, Ph.D., Research Advisor, Chemistry, Eli Lilly & Co
- Neil Burford, Ph.D., Sr Research Investigator II, Lead Discovery, Bristol Myers Squibb Co
- Kyle Butler, Ph.D., Graduate Research Asst, Medicinal Chemistry & Pharmacognosy, Univ Of Illinois Chicago
- Robert Carithers, Prof of Medicine, Gastroenterology, Univ of Washington
- Gregory Carven, Assoc Research Fellow & Head, Global Biotherapeutics Technologies, Pfizer Research Labs
- Robert Casero Jr, Ph.D., Prof, Oncology Cancer Biology, Johns Hopkins Univ
- Sylvain Celanire, Ph.D., Assoc Research Dir Medicinal Chemistry, Medicinal Chemistry, Addex Therapeutics
- DeKuan Chang, Research Fellow, Cancer Immunology & AIDS, Dana Farber Cancer Institute
- Zhongyi Cheng, PTM Biolabs Inc
- Xiaodong Cheng, Ph.D., Professor & Georgia Eminent Scholar, Biochemistry, Emory Univ
- Partha Chowdhury, Principal Scientist, Antibody Discovery & Protein Engineering, MedImmune
- Ruiyin Rick Chu, Principal Investigator, Functional Genomics, Genzyme Corp A Sanofi Co
- Namjin Chung, Sr Research Investigator, Applied Genomics, Bristol Myers Squibb Co
- John Corbin, Assoc Dir Molecular Interactions & Biophysics, Preclinical Research, XOMA US LLC
- Alan Corin, Ph.D., Dir Biochemistry & Molecular Pharmacology, Biochemistry & Molecular Pharmacology, Celgene
- Charles Craik, Prof, Pharmaceutical Chemistry, Univ of California San Francisco
- Danette Daniels, Ph.D., Grp Leader, R&D Functional Proteomics, Promega Corp
- Hans De Haard, Ph.D., CSO, Research, arGEN X BVBA
- Ario De Marco, Ph.D., Dir Biotechnological Platform, Therapeutic Antibody Platform, Institut Curie
- Gerald Denis, Ph.D., Asst Prof, Cancer Ctr, Boston Univ
- John Denu, Ph.D., Prof, Biomolecular Chemistry, Univ of Wisconsin Madison
- Paul Diehl, Dir Marketing & Bus Dev, Marketing & Bus Dev, Cellecta Inc
- Rajan Dighe, Ph.D., Prof, Molecular Reproduction & Dev & Genetics, Indian Institute of Science
- Marcel Dinger, Ph.D., Assoc Prof & Head Clinical Genomics, Clinical Genomics Ctr, Garvan Institute of Medical Research
- Hakim Djaballah, Dir HTS Core Facility, Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Ctr
- John Doench, Scientist, RNAI Platform, Broad Institute
- Dario Doller, Ph.D., Dir Discovery Chemistry & DMPK, Discovery Chemistry & DMPK, Lundbeck Research USA
- Yali Dou, Ph.D., Assoc Prof, Pathology, Univ of Michigan
- John Douhan, Ph.D., Principal Scientist, Inflammation, Pfizer Research Labs
- Frederic Ducancel, Head, Institute of Biology and Technology, CEA Saclay
- Donald Durden, M.D., Ph.D., CEO, SignalRx Pharmaceuticals Inc
- Hilmar Ebersbach, Lab Head, Antibody Generation, Novartis Pharma AG
- Christophe Echeverri, CEO & CSO, Cenix BioScience USA Inc
- Pascal Egloff, Scientist, Biochemistry Institute, Univ Of Zurich
- Daniel Erlanson, Ph.D., Co Founder & President, Chemistry, Carmot Therapeutics Inc
- Marco Falasca, Ph.D., Prof, Molecular Pharmacology & Diabetes, Queen Mary Univ of London
- John Feder, Assoc Dir Genome Biology, Genome Biology, Bristol Myers Squibb Co
- Paul Feldman, Ph.D., VP Medicinal Chemistry, Medicinal Chemistry, GlaxoSmithKline
- Maria Francipane, Ph.D., Postdoc Research Scholar, Pathology, Univ of Pittsburgh
- Christopher French, M.D., Asst Prof, Pathology, Brigham & Womens Hospital
- Jordan Fridman, Ph.D., Exec Dir, Incyte Corp
- Matthew Fuchter, Ph.D., Sr Lecturer, Synthetic & Medicinal Chemistry, Imperial College London
- George Gaitanaris, M.D., Ph.D., VP Science, Science, Omeros Corp
- Alex Gaither, Lab Head, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research Inc
- Matthew Gardener, Ph.D., Sr Scientist, ADPE, MedImmune Ltd
- Gilles Gnacadja, Ph.D., Principal Analyst, System Informatics, Amgen Inc
- Val Goodfellow, Ph.D., CEO, Califia Bio Inc
- Daniel Grau, Ph.D., , Heptares Therapeutics Ltd
- David Grayzel, Managing Dir, Atlas Venture
- Leonard Guarente, Prof, Biology, Massachusetts Institute of Technology
- Lorraine Gudas, Ph.D., Chairman, Pharmacology, Cornell Univ
- Wayne Hancock, Prof & Chief, Pathology & Transplantation Immunology, Childrens Hospital of Philadelphia
- Michael Hanson, Ph.D., Dir Structural Biology, Structural Biology, Receptos Inc
- William Harriman, CSO & Founder, Crystal Bioscience
- Joseph Hill, Prof, Internal Medicine & Molecular Biology, Univ of Texas Dallas
- Gregory Hoffman, , Systems Biology, Harvard Medical School
- Edward Holson, Dir Medicinal Chemistry, Medicinal Chemistry, Broad Institute
- Corey Hopkins, Ph.D., Asst Prof, Neuroscience Drug Discovery Ctr, Vanderbilt Univ
- Catherine Hutchings, Ph.D., Antibody Project Manager, Antibody Discovery & Strategic Partnering, Heptares Therapeutics Ltd
- Lindsey Ingerman James, Ph.D., Research Asst Prof, Ctr for Integrative Chemical Biology & Drug Dis, Univ of North Carolina Chapel Hill
- Anass Jawhari, Ph.D., CSO, Membrane Protein Alliance
- Xuliang Jiang, Ph.D., Assoc Dir Structural Biology & Computational Chem, Structural Biology & Computational Chemistry, EMD Serono Research & Development Institute Inc
- Jan Johansson, M.D., Ph.D., CEO & President, Corp, Artery Therapeutics Inc
- Paul Kassner, Dir Research, Research, Amgen Inc
- Vsevolod Katritch, Ph.D., Asst Prof, Molecular Biology, Scripps Research Institute
- Debra Kendall, Ph.D., Prof, Pharmaceutical Sciences, Univ Of Connecticut Storrs
- Eldar Kim, CSO, MSM Protein Technologies Inc
- Chadwick King, Principal Scientist, Biologics Discovery, Amgen Inc
- Sarah Knutson, Ph.D., Senior Scientist, Biological Sciences, EpiZyme Inc
- Friedrich Koch-Nolte, Prof, Molecular Immunology, Univ Medical Ctr Hamburg Eppendorf
- Suneil Koliwad, M.D., Ph.D., Asst Prof, Diabetes Ctr, Univ of California San Francisco
- Christopher Koth, Sr Scientist, Structural Biology, Genentech Inc
- Ryan Kruger, Ph.D., Manager, Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline
- Tatiana Kutateladze, Ph.D., Assoc Prof, Pharmacology, Univ of Colorado Denver
- Susan Lacy, Assoc Dir Global Biologics, Global Biologics, AbbVie Bioresearch Ctr
- Kyung Lee, Ph.D., Sr Investigator & Section Head, Lab of Metabolism, NIH NCI
- Sophie Lelievre, Assoc Prof, Basic Medical Sciences & Cancer Ctr, Purdue Univ
- Min Li, Prof, Neuroscience, Johns Hopkins Univ
- Hong Liang, Ph.D., Associate Research Fellow, Rinat Pfizer
- Changlu Liu, Ph.D., Principal Scientist, Neurosciences, Johnson & Johnson Pharmaceutical R&D
- Xiangdong Liu, Ph.D., Grp Head, Drug Discovery & Dev, Incyte Corp
- Mercedes Lobera, Assoc Dir, Tempero Pharmaceuticals Inc
- Silvia Locatelli-Hoops, Scientist, Membrane Biochemistry and Biophysics, NIH NIAAA
- Brian Lohse, Ph.D., Assoc Prof, Drug Design & Pharmacology, Univ Of Copenhagen
- Udo Maier, Ph.D., Head, Target Discovery Research, Boehringer Ingelheim Pharma GmbH & CO KG
- Scott Martin, Team Leader RNAi Screening, Chemical Genomics Ctr, NIH NCATS
- Lesley Mathews, Contractor, Pre Clinical Innovation, NIH NCATS
- Ralph Mazitschek, Asst Prof, Ctr for Systems Biology, Massachusetts General Hospital
- Michael McCabe, Ph.D., Investigator, Biology, GlaxoSmithKline
- Timothy McKinsey, Assoc Prof & Assoc Head Translational Research, Cardiology Medicine, Univ of Colorado Denver
- Gregory Michaud, Sr Investigator I, Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research Inc
- Alea Mills, Ph.D., Prof, Functional Genomics, Cold Spring Harbor Lab
- Pamela Munster, Prof in Residence, Hematology & Oncology, Univ of California San Francisco
- Andrew Niles, Sr Research Scientist, Promega Corp
- Scott Noggle, Dir Lab, Lab, New York Stem Cell Foundation
- Udo Oppermann, Ph.D., Structural Genomics Consortium, Univ of Oxford
- Michael Orsini, Ph.D., Principal Scientist, Metabolic Diseases, Bristol Myers Squibb Co
- Dafydd Owen, Ph.D., Assoc Research Fellow, Pfizer Worldwide Medicinal Chemistry, Pfizer Global R&D
- Harish Pant, Ph.D., Lab Chief, Neuronal Cytoskeletal Protein Regln, NIH NINDS
- Kristen Picha, Dir Centyrex, Biology, Janssen US
- William Pitts, Ph.D., Grp Leader, Medicinal Chemistry, Bristol Myers Squibb Co
- Kornelia Polyak, M.D., Ph.D., Assoc Prof, Medical Oncology, Dana Farber Cancer Institute
- Prem Premsrirut, President & CEO, Mirimus Inc
- Pier Lorenzo Puri, Assoc Prof, Childrens Health Research Ctr, Sanford Burnham Medical Research Institute
- Kamal Puri, Ph.D., Assoc Dir Research, Research, Gilead Sciences Inc
- Elizabeth Quinn, Dir Marketing, LeadHunter Discovery Svcs, DiscoveRx Corp
- Palaniswami Rathanaswami, Sr Scientist, Amgen Inc
- Peter Ravn, Ph.D., Sr Research Scientist, MedImmune Ltd
- Aaron Ring, Graduate Student, Structural Biology, Stanford Univ
- John Robinson, Ph.D., Sr Scientist, Medicinal Chem, Array BioPharma Inc
- David Root, Dir RNAi Platform, RNAi Platform, Broad Institute
- Mette Rosenkilde, Ph.D., Prof, Pharmacology & Neuroscience, Univ of Copenhagen
- Heiko Runz, Principal Investigator & Specialist Medical Gen, Molecular Medicine Partnership, Univ of Heidelberg
- Thomas Sakmar, Ph.D., Richard M & Isabel P Furlaud Prof, Chemical Biology & Signal Transduction, Rockefeller Univ
- Yoshitaka Satoh, Ph.D., Sr Principal Scientist, Medicinal Chemistry, Celgene Corp
- Stephan Schann, Ph.D., Head, Research, Domain Therapeutics
- Matthieu Schapira, Ph.D., Prof, Structural Genomics Consortium, Univ of Toronto
- Jerome Schentag, PharmD, Prof, Pharmaceutical Sciences, SUNY Buffalo
- Stuart Schreiber, Ph.D., Dir, Chemical Biology Program, Broad Institute
- Eric Schwartz, Ph.D., Sr Dir Chemistry, Chemistry, Celgene
- Margrit Schwarz, Ph.D., MS Consulting LLC, Email Address Only
- Fiona Scott, Ph.D., Assoc Dir, Biology, Receptos Inc
- Jeffrey Settleman, Ph.D., Sr Dir Discovery Oncology, Discovery Oncology, Genentech Inc
- Shawn L. Shafer, Ph.D., Market Segment Manager, Functional Genomics, Sigma® Life Science
- Caroline Shamu, Lecturer, Systems Biology, Harvard Medical School
- David Sheppard, Ph.D., Dir Computational Chemistry, Computational Chemistry, BioFocus
- David Sherris, Ph.D., President & CEO, Paloma Pharmaceuticals Inc
- Arun Shukla, Asst Prof, Medicine, Duke Univ
- Gerald Shulman, Prof, Cellular & Molecular Physiology, Yale Univ
- Robert Sims, Ph.D., Dir Biology, Biology, Constellation Pharmaceuticals
- Jennifer Smith, Asst Dir, ICCB Longwood Screening Facility, Harvard Medical School
- Bryan Smith, Ph.D., Sr Scientist II, Biology, Deciphera Pharmaceuticals
- Arjan Snijder, Assoc Prin Scientist, Discovery Sciences, AstraZeneca R&D Molndal
- Yongcheng Song, Ph.D., Research Scientist Fellow, Chemistry, Univ Of Illinois Urbana
- Jun Sonoda, Ph.D., Scientist, Molecular Biology, Genentech Inc
- Ajit Srivastava, Ph.D., Consultant, Integrated Pharma Solutions LLC, Individual Consultant
- Peter Staller, Ph.D., Dir Oncology Research, Oncology Research, EpiTherapeutics ApS
- Kimberly Stegmaier, M.D., Asst Prof, Pediatrics, Dana Farber Cancer Institute
- Jan Steyaert, Ph.D., Head, Structural Biology Brussels Research Ctr, Vrije Univ Brussels
- William Strohl, Ph.D., VP Biologics Research, Biologics Research, Janssen Pharmaceuticals Inc
- Hosahalli Subramanya, Ph.D., VP Lead Generation, Structural Biology, Aurigene Discovery Technologies Ltd
- Roger Sunahara, Ph.D., Asst Prof, Pharmacology, Univ of Michigan
- Ronald Swanson, Sr Dir Biologics Research, Biologics Research, Janssen R&D LLC
- Alan Tackett, Ph.D., Dir UAMS Proteomics Facility & Assoc Prof, Biochemistry & Molecular Biology, Univ of Arkansas for Medical Sciences
- Christopher Tate, Ph.D., Grp Leader, MRC Lab Of Molecular Biology
- Rebecca Taub, M.D., Ph.D., CEO, Madrigal Pharmaceuticals
- Sean Taverna, Ph.D., Asst Prof, Pharmacology & Molecular Sciences, Johns Hopkins Univ
- Donato Tedesco, Sr Research Scientist, Cellecta Inc
- Douglas Thomas, Ph.D., Assoc Prof, Medicinal Chemistry, Univ Of Illinois Chicago
- Helmut Thomas, Ph.D., Sr VP Research & Preclinical Dev, Research & Preclinical Dev, Tranzyme Pharma Inc
- Richard Trauger, CSO, CytoDyn Inc
- Raymond Trievel, Ph.D., Assoc Prof, Biological Chemistry, Univ of Michigan
- Patrick Trojer, Ph.D., Dir & Head Biology, Biology, Constellation Pharmaceuticals
- John Trzupek, Ph.D., Principal Scientist, Pfizer Global R&D
- Matt Tudor, Principal Scientist, Screening & Protein Sciences, Merck & Co
- Peter Tummino, Ph.D., Sr Dir Biology, Biology, GlaxoSmithKline
- Alexandros Tzatsos, M.D., Ph.D., Molecular Oncology Research Institute, Tufts Univ
- David Unett, Ph.D., Sr Dir Receptor Pharmacology & Screening, Receptor Pharmacology & Screening, Arena Pharmaceuticals
- Stefanie Urlinger, Ph.D., Dir R&D, Discovery Alliances & Technologies, MorphoSys AG
- Jonathan Violin, Ph.D., Head, Biology, Trevena Inc
- Bridget Wagner, Dir Pancreatic Cell Biology, Chemical Biology Program, Broad Institute
- Gangli Wang, Ph.D., Chemistry, Univ Of North Carolina Chapel Hill
- Shaomeng Wang, Ph.D., Prof, Internal Medicine & Pharmacology, Univ of Michigan
- John Watson, Ph.D., Sr Research Investigator, Lead Discovery, Bristol Myers Squibb Co
- Dale Wright, Ph.D., Research Investigator, Pharmacology, Array BioPharma Inc
- Hong Xin, Ph. D., Sr Scientist, Lead Generation, Johnson & Johnson Pharmaceutical R&D
- Qin Yan, Ph.D., Asst Prof, Pathology, Yale Univ
- Tso-Pang Yao, Prof, Pharmacology & Cancer Biology, Duke Univ
- Erick Young, Ph.D., Distinguished Research Fellow, Medicinal Chemistry, Boehringer Ingelheim Pharma
- Edward Zartler, Ph.D., President and CSO, Quantum Tessera Consulting LLC
- Mei Zhang, Sr Scientist, LDT, EMD Serono Research & Development Institute Inc
- Yingming Zhao, Prof, Cancer Research, Univ of Chicago
- Ting Zhao, , Cardiovascular Surgery, Boston Univ
- Qiang Zhou, Scientist, Neuroscience, Genentech Inc
- Ming-Ming Zhou, Ph.D., Prof & Chair, Structual & Chemical Biology, Icahn School of Medicine at Mount Sinai
- Zhaohui Sunny Zhou, Ph.D., Assoc Prof, Barnett Institute, Northeastern Univ
|
|
|
|
|
|
Deadline for Abstracts:
|
|
---
|
|
|
|
|
|
Registration:
|
|
Register now
|
|
E-mail:
|
|
kwaterman@healthtech.com
|
|
|
|
|
|
|
|